Antikinetoplastid antimitotic activity and metabolic stability of dinitroaniline sulfonamides and benzamides.
Antikinetoplastid antimitotic activity and metabolic stability of dinitroaniline sulfonamides and benzamides.
复制标题
DOI:
10.1016/j.bmc.2006.04.017
复制
发表时间:
2006-08
影响因子:
3.5
通讯作者:
Tesmol G. George;Jayaseharan Johnsamuel;Dawn A. Delfín;A. Yakovich;Mitali Mukherjee;M. Phelps;J. Dalton;D. Sackett;M. Kaiser;R. Brun;K. Werbovetz
中科院分区:
文献类型:
--
作者:
Tesmol G. George;Jayaseharan Johnsamuel;Dawn A. Delfín;A. Yakovich;Mitali Mukherjee;M. Phelps;J. Dalton;D. Sackett;M. Kaiser;R. Brun;K. Werbovetz
N1-Phenyl-3,5-dinitro-N4,N4-di-n-propylsulfanilamide (1) and N1-phenyl-3,5-dinitro-N4,N4-di-n-butylsulfanilamide (2) show potent in vitro antimitotic activity against kinetoplastid parasites but display poor in vivo activity. Seventeen new dinitroaniline sulfonamide and eleven new benzamide analogs of these leads are reported here. Nine of the sulfonamides display in vitro IC50values under 500nM against African trypanosomes, and the most active antikinetoplastid compounds also inhibit the in vitro assembly of purified leishmanial tubulin with potencies similar to that of 2. While several of the potent compounds are rapidly degraded by rat liver S9 fractions in vitro, N1-(3-hydroxy)phenyl-3,5-dinitro-N4,N4-di-n-butylsulfanilamide (21) displays an IC50value of 260nM against African trypanosomes in vitro and is more stable than 2 in the in vitro metabolism assay.